A Familial Phenotypic and Genetic Study of Mutations in PFN1 Associated with Amyotrophic Lateral Sclerosis

  • Jieshan Chi
  • Junling Chen
  • Yan Li
  • Zhiheng Huang
  • Lijuan Wang
  • Yuhu ZhangEmail author
Letter to the Editor

Dear Editor,

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease that prominently affects both upper and lower motor neurons. The prevalence of ALS has been estimated at 2.6–3.0 per 100,000 in Europe, 5.2 per 100,000 in the USA, and 1.9–9.9 per 100,000 in Asia [1, 2, 3]. ALS is classified as sporadic (sALS) or familial (fALS), but only 5%–10% of cases are identified as familial [4, 5]. In 1993, the first mutation associated with ALS was found in the superoxide dismutase 1 (SOD1) gene [6]. Since then, > 30 genes with such mutations have been reported, of which four genes SOD1, FUS (FUS RNA binding protein), TARDBP (TAR DNA binding protein), and C9orf72 (C9orf72-SMCR8 complex subunit), account for 60%–70% of fALS cases and 10% of sALS cases [5]. The discovery of mutations in these genes has established a pivotal rationale for understanding the pathogenic processes and mechanisms in ALS. In particular, mitochondrial dysfunction, disruption of RNA...



We sincerely thank the patients and their families for their cooperation. This work was supported by the Key Program of the Natural Science Foundation of Guangdong Province, China (2017B030311015), Guangzhou Municipal People’s Livelihood Science and Technology Project (201803010085), and the National Key R&D Program of China (2017YFC1310200).

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

12264_2019_448_MOESM1_ESM.pdf (294 kb)
Supplementary material 1 (PDF 294 kb)


  1. 1.
    Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010, 81: 385–390.CrossRefGoogle Scholar
  2. 2.
    Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2015. MMWR Morb Mortal Wkly Rep 2018, 67: 1285–1289.CrossRefGoogle Scholar
  3. 3.
    Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry 2016, 87: 821–830.CrossRefGoogle Scholar
  4. 4.
    Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet 2018, 34: 404–423.CrossRefGoogle Scholar
  5. 5.
    Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature 2016, 539: 197–206.CrossRefGoogle Scholar
  6. 6.
    Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014, 17: 17–23.CrossRefGoogle Scholar
  7. 7.
    Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 2012, 488: 499–503.CrossRefGoogle Scholar
  8. 8.
    Ingre C, Landers JE, Rizik N, Volk AE, Akimoto C, Birve A, et al. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 2013, 34: 1708. e1–6.CrossRefGoogle Scholar
  9. 9.
    Chen Y, Zheng ZZ, Huang R, Chen K, Song W, Zhao B, et al. PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiol Aging 2013, 34: 1922. e1–5.CrossRefGoogle Scholar
  10. 10.
    Figley MD, Bieri G, Kolaitis RM, Taylor JP, Gitler AD. Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J Neurosci 2014, 34: 8083–8097.CrossRefGoogle Scholar
  11. 11.
    Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hasegawa M. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum Mol Genet 2016, 25: 1420–1433.CrossRefGoogle Scholar
  12. 12.
    Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, et al. Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum Mol Genet 2017, 26: 686–701.PubMedGoogle Scholar
  13. 13.
    Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener 2015, 16: 291–292.CrossRefGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS 2019

Authors and Affiliations

  1. 1.Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhouChina

Personalised recommendations